EUVIMEDEUVIMED entdecken
Crossref

Improved Clinical Outcomes with the Combination Therapy of a Glucagon-like Peptide-1 Receptor Agonists and a Sodium-glucose Cotransporter-2 Inhibitor in Overweight/Obese People with Type 2 Diabetes: Real-world Evidence from the Indian Subcontinent

Anant Nigam

Journal of The Association of Physicians of India · 2024

DOI: 10.59556/japi.72.0644 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of The Association of Physicians of India, 2024. Verfasst von Anant Nigam. Beteiligte Einrichtung: Director, Nigam Diabetes Center, Jaipur, Rajasthan, India, Corresponding Author. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Sodium-Glucose Transporter 2 Inhibitors, Drug Therapy, Combination, Obesity. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Sodium-Glucose Transporter 2 InhibitorsDrug Therapy, CombinationObesityOverweightHypoglycemic AgentsCanagliflozinGlucagon-Like Peptide-1 Receptor AgonistsHumansMaleFemaleMiddle AgedIndiaRecombinant Fusion ProteinsAdultRetrospective StudiesGlucagon-Like PeptidesGlycated HemoglobinTreatment OutcomeImmunoglobulin Fc Fragments

Substanzen

Sodium-Glucose Transporter 2 InhibitorsHypoglycemic AgentsCanagliflozindulaglutideRecombinant Fusion ProteinsGlucagon-Like PeptidesGlycated HemoglobinGlucagon-Like Peptide-1 Receptor AgonistsImmunoglobulin Fc Fragments

Autor:innen und Institutionen

  • Director, Nigam Diabetes Center, Jaipur, Rajasthan, India, Corresponding Author.

Zitieren

APA

Nigam, A. (2024). Improved Clinical Outcomes with the Combination Therapy of a Glucagon-like Peptide-1 Receptor Agonists and a Sodium-glucose Cotransporter-2 Inhibitor in Overweight/Obese People with Type 2 Diabetes: Real-world Evidence from the Indian Subcontinent. Journal of The Association of Physicians of India. https://doi.org/10.59556/japi.72.0644

Vancouver

Nigam A. Improved Clinical Outcomes with the Combination Therapy of a Glucagon-like Peptide-1 Receptor Agonists and a Sodium-glucose Cotransporter-2 Inhibitor in Overweight/Obese People with Type 2 Diabetes: Real-world Evidence from the Indian Subcontinent. Journal of The Association of Physicians of India. 2024. doi:10.59556/japi.72.0644

BibTeX
@article{Nigam2024,
  author = {Nigam, Anant},
  title = {Improved Clinical Outcomes with the Combination Therapy of a Glucagon-like Peptide-1 Receptor Agonists and a Sodium-glucose Cotransporter-2 Inhibitor in Overweight/Obese People with Type 2 Diabetes: Real-world Evidence from the Indian Subcontinent},
  journal = {Journal of The Association of Physicians of India},
  year = {2024},
  doi = {10.59556/japi.72.0644}
}
Kostenlos starten →